Please login to the form below

Equipping your medical affairs teams with solutions to navigate the healthcare landscape

Dr Tyler Ray, OPEN Health Medical Communications

The healthcare landscape has experienced a significant transformation in the past two decades. The advancement in digital health technology, the availability of ‘big data’ and a focus on a value-for-patient economic environment are just some of the major contributing factors driving current trends.

The evolving changes in healthcare have highlighted the importance and relevance of medical affairs teams in the pharmaceutical and biotechnology industries. Medical affairs teams, with Medical Science Liaisons (MSLs) at their core, are now consistently recognised to be fundamental in companies’ strategies and value propositions. Traditionally, medical affairs teams and MSLs were often seen as a supporting function. However, given recent industry transformations and new requirements, medical affairs teams are now being described as the ‘third strategic pillar’ of a successful organisation and are increasingly considered to be equally as important as research and development (R&D) and commercial counterparts.1

The role of an MSL has progressively evolved since it was first established by the Upjohn Company in 1967.MSLs provide a crucial link between healthcare companies and healthcare decision makers, widely defined as physician, payer and patient. MSLs are a key resource within an organisation. They are central to providing scientific advice, training and insight generation, which is essential for overall company strategy development and implementation. External scientific engagement and exploration of mutual scientific and clinical interests by MSLs adds significant value to clinical practice, ultimately benefiting patients. MSLs Healthcare decision makers and providers are increasingly forming alliances with MSLs and medical affairs teams to help improve their understanding of the complex science and targeted medical treatments that are becoming widely available. These alliances are crucial for evidence- and value-based clinical decision making and deliver substantial benefits for research, healthcare education and patients.3

With such rapid changes in the industry and the increasing importance of medical affairs teams, what training programmes are needed to build a multifaceted and highly skilled team?

1 . A vision for medical affairs in 2025.

2 . Morgan DK et al. History and evolution of field-based medical programs. Drug Inf J 2000;34:1049–1052.

3 . Doran E et al. Empirical uncertainty and moral contest: a qualitative analysis of the relationship between medical specialists and the pharmaceutical industry in Australia. Soc Sci Med 2006;62:1510–1519.

Pink divider

At OPEN Health Learning & Development, we step beyond traditional industry and medical affairs training programmes by developing your team’s knowledge, competencies and confidence.

We believe that medical affairs training programmes should have a focus on:

  1. Learner training needs developed from thorough analyses that are aligned to the specific requirements of medical affairs business units
  2. Enhancing a medical affairs team’s understanding of scientific content, stakeholder management principles and information management solutions
  3. Skills training that allows users to meet competencies that are tailored to the core medical affairs principals of communication, science, strategy and ethics

By combining the above, drawing on best practices in adult learning theory and leveraging technologies to achieve blended learning, programmes are designed with outcomes in mind to help clients maximise their teams’ potential and act as credible partners across the healthcare community.

Your teams are your most powerful tool; equipping them with the right resources will enhance their performance and maximise their potential, allowing you to set and implement smart and effective strategies for your business.

Pink divider

If you would like to know more about how OPEN Health Learning & Development can work in partnership with you to execute your internal training needs, please do get in touch.

26th February 2020


Company Details

OPEN Health

+44 1628 481112

Contact Website

The Weighbridge
Brewery Courtyard
High Street
United Kingdom

Latest content on this profile

OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health
OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health
OPEN Health
OPEN Health Appoints David P. King as Non-Executive Chairman and Paul Carter as Independent Board Member
OPEN Health has announced additions to its board of directors, appointing David P. King as non-executive Chairman and Paul Carter as an independent board member.
OPEN Health
Steve Chick joins OPEN Health as Chief Growth Officer for Evidence & Access
OPEN Health is pleased to announce the appointment of Stephen J. Chick as Chief Growth Officer for OPEN Health Evidence & Access.
OPEN Health
OPEN Health to acquire leading US medical communications platform The CM Group from NaviMed Capital
OPEN Health, a pre-eminent global provider of scientific communications and market access services, announced that it signed a binding agreement to acquire The CM Group, a leading US domestic medical communications platform from NaviMed Capital (“NaviMed”).
OPEN Health
How digital health is changing the relationship between patients and health providers | OPEN Health
The pandemic has forced pharmaceutical industry to look at digital in a new way - and it’s driving better health outcomes
OPEN Health
David Thompson joins OPEN Health as Chief Executive Officer for Evidence & Access
David Thompson joins OPEN Health as Chief Executive Officer for Evidence & Access
OPEN Health